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Validation of the VEINES-QOL quality of life
instrument in venous leg ulcers: repeatability
and validity study embedded in a randomised
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Abstract
Background: VEINES-QOL/Sym is a disease-specific quality of life instrument for use in venous diseases of the leg.
Its relative scoring system precludes comparisons between studies. There were very few venous leg ulcer patients
in the validation samples. We report a validation study for venous leg ulcers and develop a scoring system which
enables comparison between studies.
Methods: Four hundred fifty-one participants in the VenUS IV trial of the management of venous leg ulcers were
asked to complete a VEINES-QOL questionnaire at recruitment, along with SF-12, pain, and other aspects of quality
of life. VEINES-QOL was repeated after two weeks and after 4 months. Healing of ulcers was confirmed by blind
assessment of digital photographs. Three scoring systems for VEINES-QOL were compared.
Results: No floor or ceiling effects were observed for VEINES-QOL items, item-item correlations were weak to
moderate, item-score correlations were moderate. Internal reliability was good. The VEINES-Sym subscale was
confirmed by factor analysis. Test-retest reliability was satisfactory for the scale scores; individual items showed
moderate to good agreement. Relationships with SF-12, pain, and the quality items confirmed construct validity.
Participants whose ulcers had healed showed greater mean increase in scores than did those yet to heal, though
they continued to report leg problems. An intrinsic scoring method appeared superior to the original relative
method.
Conclusions: VEINES-QOL was suitable for use in the study of venous leg ulcers. The intrinsic scoring method
should be adopted, to facilitate comparisons between studies.
Trial registration: VenUS IV is registered with the ISRCTN register, number ISRCTN49373072.
Background
It has been suggested that quality of life is really the right
primary outcome variable for a clinical trial (Jon Nicholl,
personal communication). Generic quality of life measures,
such as SF-36, are necessary to compare outcomes across
different populations and interventions, particularly for
cost-effectiveness studies, but they are often insensitive to
specific clinical changes which treatments are designed to
bring about [1, 2]. Disease-specific quality of life measures
may be more sensitive for the detection and quantification
of changes that are important to clinicians or patients. As a
result, comparison studies are needed of the validity, reli-
ability, and responsiveness of generic and disease-specific
measures in the same population [2].
Venous leg ulcers
Venous leg ulcers are chronic wounds that generally occur
in the region of the leg between the knee and ankle, as a
consequence of venous insufficiency [3]. The underlying
venous insufficiency and associated venous hypertension
are generally caused by venous valve dysfunction, deep vein
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occlusion or failure of the calf muscle pump [4, 5]. Venous
leg ulceration typically presents as repeated cycles of
ulceration, healing and recurrence, with ulcers typic-
ally taking weeks or months to heal [3, 6]. Once healed,
12-month recurrence rates have been estimated at be-
tween 18 and 28 % [7, 8]. These wounds are one of the
most prevalent chronic wound types in the UK, with
an estimated point prevalence of 0.16 % [9]. There is a
progressive increase in venous leg ulceration with age
and the annual UK prevalence in people of >65 years is
estimated at 1.7 % [10].
Venous leg ulcers are distressing to patients, painful,
prone to infection, malodorous and have a severe negative
impact upon patients’ mobility [9]. These all affect sufferers’
quality of life, both directly through pain and indirectly
through limitations on work capacity, social activity, self-
care and personal hygiene, and through associated depres-
sion, anxiety, and social isolation [11].
The VEINES-QOL instrument
The VEINES-QOL/Sym questionnaire is a disease-specific
quality of life instrument for chronic venous disorders of
the leg (CVDL). It had good psychometric properties when
used with a mixed sample of people with venous leg dis-
eases [12] and in people with deep vein thrombosis [13].
Although venous leg ulcer patients were included in the
original validation study [12], they were only a small part
(2 %) of the sample and results were not presented for them
separately. We would like to know how well VEINES-
QOL/Sym can measure disease-specific quality of life in pa-
tients with venous leg ulcers.
The VEINES-QOL questionnaire consists of 26 items.
It includes questions about symptoms due to CVDL
(ten items), limitations in daily activities due to CVDL
(nine items) and psychological impact (five items), as
well as questions asking about the amount of change in
the respondent’s leg problem over a 1-year period (one
item) and the time of day that the leg problem is most
intense (one item). The questions and coding are given
by Lamping et al. [12].
Of the 26 items in the questionnaire, 25 items are
combined to create a summary score (VEINES-QOL).
One item which asks about the time of day the leg problem
is most intense, question 2, provides only descriptive
information and is not scored. A subset of ten of these
items, questions 1a to 1i and 7, is used to create a
symptom score (VEINES-Sym). For both the VEINES-
QOL and VEINES-Sym scores, high values indicate
better outcomes.
The way the items are combined to form a score is un-
usual. The scores for individual questions have varying
numbers of possible answers and hence varying maximum
scores, so they cannot simply be summed. Each question is
standardised using the mean and standard deviation of the
sample being coded to give a z-score, these are averaged,
and the result transformed to T-scores (mean = 50; stand-
ard deviation = 10) [12, 14]. This is described as the method
used for SF-36 [12]. In fact, SF-36 uses means and standard
deviations obtained from a large sample of the general
population to obtain T-scores, not those from the sample
being studied [15]. Hence a calculated SF-36 score gives a
number which is relative to this large reference sample and
so we can compare SF-36 scores between studies. VEINES-
QOL scores can be compared only to other members of
the same sample. Each set of VEINES-QOL scores will
have a mean T-score = 50. If we measure a sample on two
occasions, the overall mean score will be identical, even if
between the two occasions all the ulcers heal.
Missing items in the questionnaire are handled by
averaging the remaining items after standardisation,
providing that half of the questions or more are present.
If they are not, the whole score is set to missing.
We tried to obtain a copy of the original validation
data [12]. We regret to report that Prof. Lamping has
died and we were unable to do so.
Standardising VEINES-QOL
There are several approaches we could take to calculating
the summary scores for VEINES-QOL:
1. We could use the original relative method [12, 14].
2. We could use an external standard for means and
standard deviations, as used for SF36. It would not
be possible to get a “normal” sample for this
disease-specific instrument, because all the
questions are about “your leg problem”.
3. We could use an intrinsic standard. All the
questions are scored 1, 2, 3, . . ., k, where k is the
number of categories. We could recode each item
score i to (i – 1)/(k – 1) to give each item a score
between 0 and 1 and average over the questions to
give a final score.
This study has been designed to investigate several
aspects of validity of the VEINES-QOL questionnaire for
venous leg ulcers, including dimensionality and factor
structure, internal consistency, effect of scoring method,
construct validity, repeatability or test-retest reliability,
and responsiveness to ulcer healing.
Methods
Participants
VenUS IV was a multi-centre randomised trial comparing
compression delivered by two layer hosiery and by the four
layer bandage system in the treatment of venous leg ulcers.
The details of the design and results are given elsewhere
[16, 17]. In brief, 454 participants with venous leg ulcers
were recruited, randomised and followed-up over the
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course of their treatment. Table 1 shows the characteristics
of participants at baseline. Healing was confirmed using
digital photographs, by observers blind to treatment.
Health-related quality of life and resource use data were
collected at baseline and then by postal questionnaire
at 3, 6, 9, and 12 months. The median time to healing
was estimated to be 98 days and after 1 year of follow-
up the Kaplan Meier estimate of the proportion healed
was 82.6 %. There was no evidence of a difference in
healing between the hosiery and bandage treatments.
After adjustment for baseline ulcer area, duration, and
mobility, with shared centre frailty effects, the hazard
ratio for healing (hosiery/bandage) was 0.99 (95 % CI
0.79–1.25, p = 0.96) [17].
We added the VEINES-QOL questionnaire to the
baseline questionnaire battery. For this validation
sub-study, we gave two additional postal question-
naires including only VEINES-QOL, after 2 weeks
and at 4 months. In each case, we used the original
wording [12].
Validation methods
Several aspects of validation were considered. We asked
whether all scale items were measuring aspects of the
same underlying thing by checking that all were corre-
lated with each other and with the overall composite
scale. Any items which were unrelated to any others
could possibly be omitted from the scale and any which
were very closely related to others might be superfluous.
We asked whether the scale was a single unified whole,
or whether it might contain identifiable subscales which
might represent different components of quality of life.
We did this by factor analysis. We measured how well
the items came together to form a scale using Cron-
bach’s alpha coefficient [18]. We asked whether it was
related to those things to which we might expect quality
of life to be related, convergent validity, and whether it
was unrelated to things we should not expect to be re-
lated to quality of life, divergent validity. We asked how
repeatable the score was, as a measurement which does
not give consistent results on repeated measuring cannot
be valid. We asked how responsive the score was,
whether it changed when the respondent’s disease state
changed.
Individual items
Three VEINES-QOL questions, Q3, Q6, and Q7, have
their scoring reversed before analysis. Question 4a of
VEINES-QOL is about physical limitations for daily ac-
tivities at work. One option is “I do not work”. We have
followed the VEINES-QOL coding manual in setting
question 4a to missing if this option is selected.
For each item, we estimated the percentage response
to each possible answer, the mean and standard devi-
ation of the numerical score for each question, and drew
a histogram of the distribution of the score. This enabled
us to check for floor or ceiling effects, where a large pro-
portion of respondents gave the same answer. We esti-
mated the product moment correlation coefficient
between each item and the total score. We also esti-
mated an item by item correlation matrix.
Dimensionality, factor structure, and internal consistency
These were investigated using the baseline data, col-
lected prior to application of trial treatments. We carried
out principal components analysis and calculated eigen-
values, using pairwise deletion for the correlation matrix
to handle missing data. We assessed dimensionality visu-
ally using a scree plot. After the number of possible fac-
tors had been decided, we used a varimax rotation to
examine the factor structure and present the factor load-
ings. Internal consistency was estimated by Cronbach’s
alpha coefficient. For VEINES-QOL, we estimated alpha
with question 4a for those who worked and without Q4a
for all participants.
Table 1 VenUS IV participant characteristics at baseline
Number recruited 454a
Male (n (%)) 230 (50.7 %)
Age (years) (Mean (SD)) 68.6 (14.5)
Body mass index (kg/m2) (Mean (SD)) 31.0 (8.0)
Mobility
Participant walks freely (n (%)) 289 (63.8 %)
Participant walks with difficulty (n (%)) 160 (35.3 %)
Participant is immobile (n (%)) 4 (0.9 %)
SF-12 quality of life score (Mean (SD))b
Physical component 38.4 (11.2)
Mental component 49.6 (11.3)
Diabetes 78 (17.2 %)
Ulcer area (cm2) (median (IQR)) 3.9 (1.6, 8.7)
Ulcer duration (months)) (median (IQR)) 4.0 (2.0, 11.0)
Time since first ulcer (months) (median (IQR)) 36.0 (4.0, 120.0)
Total ulcers on reference leg (n) (median (IQR)) 1.0 (1.0, 2.0)
Reference leg
Left (n (%)) 256 (56.4 %)
Right (n (%)) 198 (43.6 %)
Ankle mobility of reference leg (n (%))
Participant has full range of motion 313 (68.9 %)
Reduced range of ankle motion 132 (29.9 %)
Participant’s ankle is fixed 9 (2.0 %)
Ankle brachial pressure index of reference
leg (Mean (SD))
1.1 (0.1)
Key: IQR = Interquartile range, SD = Standard deviation
aFor some variables a small number of observations are missing
bin general population, we expect mean = 50, SD = 10
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Scoring systems
The composite VEINES-QOL score and the symptom
subscale were calculated in three ways:
1. using the original, relative method.
2. using the baseline score in this study as the external
standard, thus giving, for the baseline data, identical
scores for the original relative method and for the
external standard.
3. using intrinsic scaling, multiplying by 100 and
rounding to the nearest integer to give a more
manageable score.
In each case, the total score was set to missing if more
than half the questions were not completed and the
symptom score was set to missing if more than five
questions from the nine parts of questions 1 and ques-
tion 7 were missing, otherwise the available average of
the available questions was taken. The artificial “missing”
data for question 4a when participants did not work was
included in the count for the full score.
For the original, external, and intrinsic scoring sys-
tems, we estimated the mean and standard deviation at
baseline, 2 weeks, and 4 months and presented histo-
grams of the distributions. We compared scores at base-
line and 4 months using the paired t method and
calculated correlations between the scores at each time.
Construct validity
We used the baseline data for construct validity. To ad-
dress convergent validity of VEINES-QOL and VEINES-
Sym, we estimated their relationship with other quality
of life and well-being scales. We estimated correlation
coefficients with the SF12 physical and mental subscales
and with pain over the past 24 h measured on a 21-
point numerical scale. Kendall’s tau b was estimated with
self-reported problems with mobility, self-care, interfer-
ence with usual activities, anxiety/depression, and pain/
discomfort, all on three point scales, and pain on a five-
point nominal scale. We also estimated the correlation
with size and duration of ulcer, using a log transform-
ation as each had a highly skewed distribution.
For divergent validity, we estimated the relationship
with two variables unrelated to the ulcer, calculating the
correlation with age and the mean score difference be-
tween sexes, compared by the two-sample t method.
Repeatability
This was estimated using the baseline and 2-week data,
omitting any participants whose ulcers had healed by
2 weeks. For each individual item, weighted kappa statis-
tics was estimated using quadratic weights. Repeatability
of the score was measured by the intra-class correlation
coefficient using the test and retest scores. The standard
deviation of differences and the coefficient of repeatabil-
ity (2 × SD of differences) were estimated.
Responsiveness
Estimation of responsiveness was done using the base-
line and 4 month data. We estimated the difference in
mean change in score between participants whose ulcers
had healed at 4 months and those who remained un-
healed, presented as an effect size measured in baseline
standard deviation units. Standard errors and confidence
intervals were calculated using the two sample t method.
We also measured responsiveness using a responsive-
ness coefficient. This uses the variance of differences be-
tween observations on the same person when there
should be no change, between baseline and 2 weeks, and
when change should have taken place in at least some
participants, between baseline and 4 months. The re-
sponsiveness coefficient is then variance for change
minus variance for no change divided by variance for
change, giving a coefficient between zero and 1.00.
Software
Principal components analysis was carried out using
SPSS version 19 (IBM). All other analyses were carried
out using Stata version 10 (Stata Corp., College Station,
Texas).
Ethical approval
This trial was reviewed and approved by the Northern
and Yorkshire Research Ethics Committee (09/H0903/
25) and all participants gave informed consent. Because
of the low-risk nature of this trial (both treatments being
assessed were already being used routinely in clinical
practice), we did not judge it necessary to have a separ-
ate Data Monitoring and Ethics Committee to oversee
the trial. Instead, unmasked adverse events data, details
of patients no longer receiving randomised treatments,
and details of post-randomised exclusions were pre-
sented by the trial coordinator (RLA) and trial statisti-
cians (RG, JMB) to independent members of the Trial
Steering Committee (chair [Ian Chetter], independent
clinician [Brenda King], and independent statistician
[Jenny Freeman]) before Trial Steering Committee meet-
ings. This decision was ratified by the study sponsors
(National Institute for Health Research Health Technol-
ogy Assessment programme) and minutes of these meet-
ings were sent to the sponsors. We obtained research
governance approval for all centres.
Results
At baseline, 451 (99.3 %) questionnaires were returned,
one was blank and 374 (82.4 %) had complete VEINES-
QOL, all others had some missing items. At 2 weeks,
382 questionnaires were returned, four were blank and
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289 (63.7 %) had complete VEINES-QOL. At 4 months,
341 questionnaires were returned, one was blank and
242 (53.3 %) had complete VEINES-QOL.
Individual questions
The distribution of each scale item at baseline is shown
in Fig. 1. The maximum proportion ticking the same
box was 55 %, apart from questions with only two op-
tions where it was 65 %, so there is nothing to suggest
that there were serious floor or ceiling effects. Means
and standard deviations for each item are shown in
Table 2.
The 300 inter-item correlations had mean = 0.29, SD =
0.16, range −0.05–0.79. The product moment correlation
between each item and the total score is shown in
Table 2. All but one of the correlations exceeded 0.20
and the mean correlation was 0.55.
Internal consistency
For the whole VEINES-QOL scale, Cronbach’s alpha =
0.88 (both with and without question 4a). For the
VEINES-Sym symptom scale, alpha = 0.81.
For principal components analysis, a scree plot of
eigenvalue against component number is shown in Fig. 2.
It appears that a three-dimensional representation of the
data might be informative. The factor loadings with
three factors after varimax rotation are shown in Table 3.
Factor 1 loads on questions 4, 5, and 6. These are all
questions about interference with usual activities. Factor
2 loads on questions 1 and 7 and corresponds exactly to
the VEINES-Sym symptom subscale. Even though ques-
tions 1h and 1i have loadings less than 0.5, they still have
higher loadings for this factor than for the others. Factor
3 loads on question 8, which is about feelings. Question
3, comparing the leg problem now with a year ago, does
not load on any factor. We could use this questionnaire
to define three subscales, including the symptoms sub-
scale already defined, interference with activities, and
feelings produce by the ulcer.
Composite scale
Table 2 shows the correlations of individual items with
the intrinsic-scored VEINES-QOL. The mean correl-
ation is 0.55 for the original VEINES-QOL and 0.55 for
the intrinsic scoring (P = 0.9, paired t test).
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Fig. 1 Distribution of each VEINES-QOL question at baseline
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The results at baseline, after 2 weeks, and after 4 months
are shown in Table 4. As the internal and external stan-
dards are the same for the original coding and the external
standard at baseline, they give identical scores. After base-
line, they are no longer identical. The increase in the mean
external standard score over 4 months from 50.0 to 54.8 is
highly significant, P < 0.001, showing that an improvement
in quality of life has taken place. This is also true of the in-
trinsic coding.
The distribution of the total score at each time is
shown in Fig. 3. At baseline and at 2 weeks, the distribu-
tion is symmetrical. However, at 4 months the distribu-
tion has pronounced negative skewness. This might be
expected in a disease-specific measure for a disease from
which total recovery, at least in terms of healing of the
ulcer, is frequent. By 4 months, more than half the refer-
ence ulcers had healed. The distribution of the symptom
score at each time is shown in Fig. 4. The distribution is
Table 2 Individual item mean, standard deviation, and
correlation with total scorea
Question Mean SD Correlation with total
VEINES-QOL SCORE,
original scoring
Correlation with total
VEINES-QOL SCORE,
intrinsic scoring
1a 3.59 1.58 0.57 0.56
1b 2.75 1.56 0.62 0.61
1c 2.75 1.69 0.34 0.34
1d 3.88 1.28 0.47 0.45
1e 3.78 1.47 0.50 0.49
1f 3.56 1.53 0.54 0.53
1g 3.46 1.61 0.60 0.59
1h 2.84 1.60 0.41 0.41
1i 3.92 1.41 0.50 0.49
3 2.83 1.67 0.14 0.13
4a 2.12 0.70 0.24 0.25
4b 1.92 0.78 0.66 0.67
4c 1.73 0.75 0.67 0.68
4d 2.21 0.77 0.63 0.63
5a 1.46 0.50 0.65 0.68
5b 1.35 0.48 0.69 0.72
5c 1.37 0.48 0.69 0.72
5d 1.36 0.48 0.69 0.71
6 3.50 1.34 0.75 0.75
7 3.42 1.40 0.65 0.63
8a 3.70 1.91 0.54 0.53
8b 4.36 1.53 0.71 0.70
8c 4.67 1.63 0.63 0.63
8d 3.65 1.98 0.49 0.49
8e 3.71 2.12 0.44 0.44
Note: For a sample of 374 observations, r is significant, P < 0.05, if r > 0.10
aFor validity, all items should be correlated with the overall score
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Fig. 2 Scree plot for a principal component analysis using the
baseline data, showing a line through the points on the right
Table 3 Factor loadingsa for a three-factor model (high loadings in
bold)
Question Factor 1 Factor 2 Factor 3
1a 0.25 0.60 0.10
1b 0.28 0.69 0.07
1c 0.03 0.42 0.06
1d 0.03 0.60 0.15
1e 0.11 0.60 0.15
1f 0.17 0.61 0.15
1g 0.17 0.68 0.16
1h 0.06 0.37 0.31
1i 0.15 0.52 0.19
3 0.02 0.04 0.12
4a 0.77 0.20 −0.01
4b 0.80 0.22 0.02
4c 0.74 0.24 0.12
4d 0.59 0.35 0.07
5a 0.77 0.10 0.15
5b 0.81 0.07 0.23
5c 0.82 0.09 0.19
5d 0.81 0.12 0.16
6 0.64 0.32 0.33
7 0.37 0.56 0.18
8a 0.11 0.21 0.77
8b 0.38 0.39 0.55
8c 0.43 0.17 0.57
8d 0.16 0.16 0.65
8e 0.05 0.09 0.77
aHigh factor loadings, e.g. >0.5, indicate that the question is an important
component of the factor
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negatively skewed at each time and very much so at
4 months.
Figure 5 shows the distribution of the residuals of the
scores at 4 months after regression on score at baseline.
These have more symmetrical distributions than those
in Fig. 4 and show that the scales are suitable for use in
statistical analysis without transformation, whichever
scoring system is used.
Correlation coefficients between each pair of the three
scoring methods were 1.00 at each time. Any relation-
ship with one score will apply to the others, too.
Construct validity
First we looked at convergent validity: does the score
have positive relationships with other quality of life and
well-being scales? We compared the VEINES-QOL to
the SF-12 quality of life measure. At baseline, the mean
(SD) were 38.4 (11.2) for the physical component
summary score and 49.6 (11.3) for the mental compo-
nent summary score. Our sample has considerably poorer
quality of physical life than the SF-12 reference sample and
has very similar quality of mental life. Correlation coeffi-
cients between the SF-12 components and all scoring sys-
tems are shown in Table 5. This shows that the correlation
is stronger with the total VEINES-QOL than with VEINES-
Sym, and that all correlations are highly significant.
Pain over the past 24 h was recorded on a 21-point pain
scale where the result is a score from 0 to 100, and also on
a five-point nominal pain scale with categories “No pain”,
“Very mild pain”, “Mild pain”, “Severe pain”, “Very severe
pain”. Higher pain was related to poorer quality of life
(Table 5). We also asked a three category question about
general pain or discomfort: “I have no pain or discomfort”,
“I have moderate pain or discomfort”, “I have extreme pain
or discomfort”. This had rank correlations with VEINES-
QOL of tau b = −0.41 and with VEINES-Sym tau b = −0.40,
both P < 0.0001.
We also asked whether quality of life measured by
VEINES-QOL/Sym is related to other specific aspects of
overall quality of life: problems with mobility, problems
with self-care, interference with usual activities, and anx-
iety/depression. All showed significant negative rank
correlations of moderate strength with both VEINES-
QOL and VEINES-Sym (Table 5).
We also considered size and duration of the ulcer. These
both had highly skewed distributions so were log trans-
formed before calculation of correlation coefficients. Long
duration and large ulcers might reduce the quality of life.
Correlations were negative, as expected, but close to zero
(Table 5).
To address divergent validity, we examined the rela-
tionship between VEINES-QOL/Sym with variables un-
related to the ulcer: age and sex. The correlations with
Table 4 Composite scoresa using three different scaling methods
Baseline Two weeks Four months
Scale Mean SD Mean SD Mean SD
VEINES-QOL
Original 50.0 10.0 50.0 10.0 50.0 10.0
External standardb 50.0 10.0 49.2 10.2 54.5 11.1
Intrinsic 53.6 22.1 51.8 22.7 62.9 24.8
Symptoms
Original 50.0 10.0 50.0 10.0 50.0 10.0
External standardb 50.0 10.0 50.3 10.3 54.8 10.6
Intrinsic 58.4 23.0 59.0 23.8 69.2 24.3
adifferent methods of forming the score may produce different
numerical values
bAt baseline the external standard score is identicalto the baselinescore,
because the baseline dataset forms the standard reference set
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age are weak though highly significant (Table 5). Mean
scores were very similar for men and women and there
was no evidence of any systematic difference. For
VEINES-QOL, the mean scores were 49.6 (women) and
50.4 (men) (P = 0.4) using original or external scoring, 52.6
(women) and 54.5 (men) (P = 0.4) using intrinsic scoring.
For VEINES-Sym, the mean scores were 50.0 for both men
and women (P = 1.0) using original or external scoring and
58.5 (women) and 58.3 (men) (P = 0.9) using intrinsic
scoring.
Repeatability
We addressed repeatability using the baseline and 2-week
data. No participants were reported to have healed ulcers in
this time, so all were used to estimate agreement. For each
individual questionnaire item, weighted kappa statistics
using quadratic weights are shown in Table 6. Kappas are
between 0.42 and 0.73, so all indicate moderate or good
agreement and none are unacceptable. The highest kappa is
for Question 7, pain over the past 24 h.
For the composite scale and subscale, intra-class correl-
ation coefficients are shown in Table 7. For the full
VEINES-QOL this was ICC = 0.80 and for VEINES-Sym
ICC= 0.75. Table 7 also shows the within-subject stand-
ard deviation and the coefficient of repeatability, the
value within which 95 % of differences between pairs of
measurements on the same person are expected to be
found. It is noticeable that the ICCs are slightly larger for
the original, internally standardised scoring than for the ex-
ternal or intrinsic standardised scores. This is because the
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Fig. 4 Distribution of symptom score at three times using different scoring methods
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internally standardised scores cannot change overall be-
tween observations.
Responsiveness
At 4 months, we had VEINES-QOL questionnaires from
198 participants who had healed by 4 months and 120
questionnaires from participants who had not healed
(187 and 111 for VEINES-Sym). Table 8 shows the mean
increases in VEINES-QOL and VEINES-Sym. For both
scales and for external and intrinsic coding, the mean in-
crease was positive in both groups and greater for the
healed group. In each case this difference was significant.
However, there was considerable variability and the dif-
ferences between healed and unhealed were small. For
external coding, in terms of the standard deviation of
the baseline score (10.0), this represents 0.26 standard
deviations for VEINES-QOL and 0.23 for VEINES-Sym.
For intrinsic coding, this represents 0.25 and 0.23 re-
spectively. Responsiveness coefficients showed moder-
ate responsiveness. This coefficient measures how
much change takes place over the period in the under-
lying quantity being measured, not whether it is related
to changes in the ulcer.
Discussion
This is the first validation study of VEINES-QOL/Sym
in venous leg ulcers. It found the instrument to be re-
peatable and to have construct validity. We found that
the VEINES-Sym subscale was exactly reproduced by
factor analysis. We found that, using either external or
intrinsic scaling, VEINES-QOL/Sym was responsive to
ulcer healing.
The original validation study [12] was in a mixed
group of patients with venous disease and the second
was in deep vein thrombosis [13]. Since VenUS IV
began, three other validity studies of VEINES-QOL/Sym
have been published:
 a Norwegian version in deep vein thrombosis [19],
with 74 participants with repeat questionnaires after
7–10 days from obtained from 40 of them.
 a Turkish version in chronic venous insufficiency
[20], using 118 patients from the cardiovascular
surgery units of three hospitals.
 another, apparently independent, Turkish version in
chronic venous insufficiency [21], where of 100
patients included, 30 were given the questionnaire
twice with 24-hour intervals for test-retest.
Individual questions
These studies were all in agreement that that the scale
was reliable, reporting alpha between 0.86 and 0.94 for
VEINES-QOL and between 0.81 and 0.88 for VEINES-
Sym. One study reported means and standard deviations
for individual questionnaire items [19]. One study re-
ported principal components analysis or factor analysis
[20]. This reported a solution with seven components,
which explained 67.5 % of the total variation cumula-
tively. They do not say how the number of components
was decided, but if they used the Kaiser criterion of
eigenvalue >1.0, this would be very similar to our six
components for which eigenvalues >1.0 (Fig. 2), which
together accounted for 63.4 % of the total variance.
Table 5 Correlationsa of VEINES-QOL and VEINES-Sym at baseline with SF12 components, reported pain and other problems, size
and duration of the ulcer, and age
VEINES-QOL VEINES-Sym
Original or external Intrinsic Original or external Intrinsic
SF12 Physical r = 0.58 r = 0.58 r = 0.43 r = 0.42
SF12 Mental r = 0.58 r = 0.57 r = 0.44 r = 0.44
Pain (0–100) r = −0.60 r = −0.58 r = −0.60 r = −0.59
Pain (five categories) (Kendall’s tau b) τb = −0.42 τb = −0.41 τb = −0.43 τb = −0.42
Pain or discomfort (three categories) τb = −0.41 τb = −0.40 τb = −0.40 τb = −0.39
Mobility (three categories) τb = −0.39 τb = −0.39 τb = −0.31 τb = −0.29
Problems with self-care (three categories) τb = −030. τb = −0.30 τb = −0.23 τb = −0.23
Interference with usual activities (three categories) τb = −0.41 τb = −0.42 τb = −0.25 τb = −0.25
Anxiety or depression (three categories) τb = −0.36 τb = −0.36 τb = −0.30 τb = −0.28
Log duration of ulcer at baseline r = −0.02 (P = 0.6) r = −0.03 (P = 0.6) r = −0.02 (P = 0.6) r = −0.02 (P = 0.7)
Log area of ulcer at baseline r=−0.10 (P = 0.03) r = −0.10 (P = 0.04) r = −0.09 (P = 0.07) r = −0.09 (P = 0.07)
Age r = 0.25 r = 0.24 r = 0.26 r = 0.26
All P < 0.0001 except duration and area of ulcer
r = product moment correlation coefficient, τb = Kendall’s tau b coefficient of rank correlation
acorrelation of score with generic quality of life scales, pain, and difficulties indicate convergent validity, lack of correlation or low correlation with variables which
should not be related to quality of life, such as age and duration of ulcer, would indicate divergent validity
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In this study all but one item-scale correlation exceeded
0.20 and the mean correlation was 0.55, in line with other
studies which reported that all items had correlations with
VEINES-QOL which were greater than 0.20 [12, 13], be-
tween 0.29 and 0.78 [19], and between 0.27 and 0.62 [20].
Only one study [20] reported on the distribution of
VEINES-QOL/Sym scores, giving mean, SD, median,
skewness, kurtosis, and range. These indicated fairly
symmetrical distributions. For each scale they reported
mean = 50 and standard deviation = 10, which was
bound to happen by definition.
We reported that individual items all showed moder-
ate or good kappa-repeatability. No other study quoted
kappa statistics.
For the composite scale and subscale, intra-class cor-
relation coefficients, 0.80 and 0.75, were smaller than
the ICCs in the original validation study [12], 0.91 and
0.87 respectively for their English-speaking sample. Cor-
relation depends on the variation between subjects. We
cannot compare this between the two samples due to
the internal referencing, but it is likely that our single-
diagnosis venous leg ulcer sample is less variable than
Lamping’s multi-diagnosis sample. Other studies re-
ported 0.87 and 0.87 [13], 0.88 and 0.83 [19], and 0.97
and 0.93 [21], which may be the result of using only
24 h as the interval between questionnaires.
Construct validity
We reported correlations with SF-12 of 0.58 for the
physical component and 0.43 for the mental component.
Using SF-36, the original study [12] reported correla-
tions with the physical component of 0.62 and 0.46 with
VEINES-QOL and VEINES-Sym respectively and with
the mental component 0.19 and 0.15. In deep vein
thrombosis, the corresponding correlations were 0.63,
0.49, 0.37, and 0.29 [13] and in venous insufficiency they
were 0.7, 0.66, 0.60, and 0.50 [21]. Also in venous insuf-
ficiency, there were significant correlations with all eight
subscales of SF-36, stronger for VEINES-QOL than for
Table 7 Intraclass correlation coefficients, within subject standard deviation, and repeatability coefficient for 2-week test-retest
reliability for VEINES-QOL and VEINES-Sym
Scale and scoring ICCa SE 95 % CI Within-subject SD Repeatability coefficientb
VEINES-QOL
Original 0.80 0.019 0.76–0.83 4.5 12.5
External standard 0.79 0.019 0.75–0.83 4.6 12.8
Intrinsic 0.78 0.020 0.74–0.82 10.6 29.4
VEINES-Sym
Original 0.75 0.022 0.71–0.79 5.0 13.8
External standard 0.75 0.022 0.71–0.79 5.1 14.1
Intrinsic 0.74 0.023 0.69–0.79 11.9 33.0
aICC = intraclass correlation coefficient, which lies between 0 and 1.0. For acceptable repeatability this should be greater than 0.070
b95 % of pairs of replicate measurements on the same person will be less than this, so a larger difference would indicate a change in quality of life
Table 6 Kappa statistics for 2-week test-retest reliability for each
question in VEINES-QOLa
Question Kappa Standard error Significance
1a 0.56 0.054 P < 0.0001
1b 0.58 0.053 P < 0.0001
1c 0.44 0.053 P < 0.0001
1d 0.67 0.054 P < 0.0001
1e 0.54 0.053 P < 0.0001
1f 0.68 0.054 P < 0.0001
1g 0.59 0.054 P < 0.0001
1h 0.59 0.053 P < 0.0001
1i 0.62 0.054 P < 0.0001
3 0.56 0.052 P < 0.0001
4a 0.58 0.106 P < 0.0001
4b 0.59 0.053 P < 0.0001
4c 0.53 0.053 P < 0.0001
4d 0.46 0.053 P < 0.0001
5a 0.42 0.055 P < 0.0001
5b 0.46 0.055 P < 0.0001
5c 0.55 0.054 P < 0.0001
5d 0.48 0.054 P < 0.0001
6 0.63 0.051 P < 0.0001
7 0.73 0.052 P < 0.0001
8a 0.55 0.052 P < 0.0001
8b 0.64 0.052 P < 0.0001
8c 0.67 0.052 P < 0.0001
8d 0.61 0.052 P < 0.0001
8e 0.71 0.052 P < 0.0001
aIndividual questions should be repeatable, i.e. answers on different occasions
should be related if the questionnaire is valid
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VEINES-Sym in every case [20]. There were also signifi-
cant relationships with EQ-5D [19]. There were the ex-
pected relationships with several clinical scores and
classifications.
No one reported differences between sexes. We found
a weak positive correlation with age in contrast to re-
ported correlations of similar magnitude but opposite
direction [12], much smaller positive correlations [13],
and no evidence of a relationship [20].
Responsiveness
Only two studies [12, 13] reported evidence of respon-
siveness, but as their samples represent very different
spectra of disease and indicators of change, it is impos-
sible to compare our results directly. None of the other
studies reported on responsiveness.
Although we have evidence that VEINES-QOL scores in-
creased over time (Table 7), there was still considerable
variability, even after healing. As Fig. 4 shows, even when
the majority of participants had healed, there was great
variation in scores. The ulcer may have healed, but the
underlying disease remains and participants are at high risk
of a recurrence of ulceration. We should not think that
when the ulcer has gone our work is done.
Quality of life in venous leg ulcer patients
The poor quality of life of these venous leg ulcer patients
is shown by their mean SF-12 physical component score
of 38.4. For comparison, a review of SF-12 and SF-36
scores in cardiovascular disease [22] reported the mean
physical component to be 44.4 in hypertension patients,
38.9 in ischaemic heart disease, and 35.9 in heart failure,
so these patients had similar physical quality of life to
patients with ischaemic heart disease. For mental quality
of life, our participants’ mean score was 49.6, very simi-
lar to 50 in the standard population. This suggests that,
although some reported depression or anxiety, this was
at a similar level to the general population.
Scaling method
We have shown that the original scaling method has a dis-
advantage, in that it always produces the same mean and
standard deviation and so cannot be used to compare dif-
ferent studies and would be difficult to use to investigate
changes over time. We think that either the use of an ex-
ternal standard or our intrinsic scoring system would be
better. The external standard has the advantage that we
can obtain a T-score, where the mean and standard devi-
ation in the reference sample are 50 and10 and all other
samples can be compared to that. For VEINES-QOL/Sym,
however, we could not do this using a normal reference
group, as the questions are relevant only to people with a
leg problem. The only reference group we have is our own
leg ulcer group and this may not be relevant for patient
groups with other venous conditions. For anybody wishing
to do this, we have published our means and standard de-
viations at baseline. The intrinsic scoring method could be
used for any venous disease group and used to compare
groups and to study changes over time and this is what we
would prefer for future use. It appears to have good statis-
tical properties for a research tool. Its distribution at
4 months follow-up appears to be the closest to Normal
of the three scoring systems, for example.
Conclusions
The VEINES-QOL/Sym instrument is valid, reliable,
and responsive for people with venous leg ulcers. Scal-
ing with the external standard (even though it is in-
ternal for the baseline VEINES-QOL) performed very
slightly better than the intrinsic standard. However,
there is no way to tell whether this would be true for
other samples, especially those with a different disease
mix. The intrinsic scoring method should work in the
same way for other samples and so we propose that
this approach should be used in future. This would en-
able scores to be compared easily between studies. We
recommend that this approach should be used in fu-
ture venous ulcer studies. The adoption of the intrin-
sic scoring system would also enable VEINES-QOL/
Sym to be used for monitoring quality of life in indi-
viduals with venous leg ulcers.
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Table 8 Increase in VEINES-QOL scores for those who have healed and those who have not healed after 4 months, with responsiveness
coefficient
Scale Healed Not healed Healed minus not healeda Responsivenessb
Mean SD Mean SD Difference 95 % CI P
VEINES-QOL, external 4.7 9.7 2.1 7.9 2.6 0.5–4.7 0.01 0.50
VEINES-Sym, external 4.8 9.7 2.5 9.1 2.3 0.1–4.6 0.04 0.44
VEINES-QOL, intrinsic 9.8 22.1 4.3 17.2 5.5 0.8–10.2 0.02 0.48
VEINES-Sym, intrinsic 10.6 22.7 5.4 20.8 5.2 0.0–10.5 0.05 0.42
aBigger changes in those who have healed than in those who have not healed indicate that healing is associated with change in reported quality of life
ba value greater than zero (maximum is 1.00) indicates that the scale responds to changes over time
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